Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OSi Specialties was a leading global manufacturer of specialty silicones and organofunctional silanes, serving the healthcare, personal care, and industrial sectors. Spun off from Union Carbide in 1993, the company became a dominant player in silicone surfactants and silane coupling agents used in medical device coatings and cosmetics. It was acquired by Witco Corporation in 1995 for approximately $480 million and subsequently passed through Crompton and GE Advanced Materials. Today, its legacy products and technologies are integrated into Momentive Performance Materials. OSi's contributions to the life sciences were primarily as a high-tier material supplier for medical-grade silicones and cosmetic formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OSi Specialties.